Rishi Sunak’s Illness Rumours and the Reality Behind Them

Rishi Sunak’s involvement in a prostate cancer screening campaign was shockingly personal for a man who is frequently criticized for his financial prudence and economic strategy. The action, simple as it looked, carried a message that was both practical and deeply personal.

No dramatic diagnosis. No hushed press briefings or leaking hospital reports. Instead, a deliberate and public-facing approach to a condition affecting thousands of men annually. In May 2025, Sunak stated he had undergone a PSA test and advised others to follow suit, particularly males over 50. It was a surprisingly responsible move, particularly given how often silence surrounds men’s health.

It wasn’t a performance. It was policy anchored in experience. Sunak highlighted family members and friends afflicted by prostate cancer—fortunately, all were found early. By using that expertise, he highlighted the kind of quiet leadership that tends to go unnoticed.

He became an advocate for Prostate Cancer Research, supporting a screening effort targeting high-risk groups, especially Black males and those with family history. According to the findings, one in four Black men and one in eight white men will get prostate cancer at some point in their lives. The disparity is glaring, and the necessity for early detection is especially evident.

Sunak’s advocacy for improved diagnostics is based on positive data. A new blood test—EpiSwitch PSE—has showed 94% accuracy in trials. That might drastically minimize unneeded scans and biopsies, and importantly, it’s a reminder that early detection doesn’t just save lives—it saves dollars too.

However, there is disagreement around Sunak’s association with sickness. Just a year earlier, during his time in power, he provoked a countrywide controversy by calling out what he labeled as the UK’s “sick note culture.” The word alone was polarising, putting doubt on those who signed off work for mental health reasons like depression and anxiety.

He advocated modifications to the system, urging that assessments be taken out of GPs’ hands and placed with specialist work and health professionals. Critics considered the concept ill-informed, even dangerous. Families, medical professionals, and advocacy organizations reacted emotionally—and frequently violently. For many, it felt like a dismissal of invisible sickness.

I remember reading one letter from a retired GP who described people “hitting a wall” under the load of many life stresses. That phrase remained with me. It encapsulated a really human quality that bureaucracy frequently ignores.

Sunak defended the ideas as part of a broader campaign to reform assistance and increase economic involvement. His argument: that over-medicalising life’s regular challenges might do more harm than good. But for individuals dealing with chronic ailments, or languishing in the long NHS mental health queues, his tone came across as contemptuous.

That contrast—between cancer supporter and mental health sceptic—has led to confusion. But it also refers to a greater problem in modern governance: how to discriminate between structural issues and individual accountability, how to balance compassion with control.

To his credit, Sunak didn’t disappear after office. By championing prostate cancer awareness, he reframed his public image, this time with an emphasis on collective welfare. He didn’t present himself as a patient. He didn’t claim martyrdom. He showed up for a test, shared it openly, and utilized his position to make the case for others to do the same.

In that setting, his health disclosure was extremely effective—not because it highlighted vulnerability, but because it presented a proactive pattern. It quietly urged men to cease disregarding symptoms, to start taking their bodies seriously. That kind of influence is tough to assess, but possibly lifesaving.

His argument for focused screening also had a deeper implication: that not all health measures need to be reactive or punishing. Some can be preventative and inclusive, addressing inequities before they widen further. This attitude adjustment felt particularly novel, especially when juxtaposed against his former statements on welfare.

A simple hospital snapshot, or a clip from a lab visit, becomes fodder for speculations. However, no reliable source indicates that he has had a significant illness. His public appearances are consistent. His speech stays clear. His role as MP continues.

This isn’t the narrative of a politician battling disease behind closed doors. It’s the story of a former leader opting to face a national health issue with the same technique he once brought to the economy: data, action, and public participation.

It’s not flawless. There is some friction. But it’s forward-looking.

Whether or not Sunak’s initiatives on mental health and work will age well remains questionable. But his contribution to prostate cancer awareness, particularly at a time when early diagnosis is quickly improving, is indisputably helpful.

By normalising the act of getting tested, by amplifying the voices of survivors, and by pressing for equal screening, he’s doing more than altering health policy—he’s potentially reshaping outcomes.

And for many guys watching from the sidelines, that’s more than enough cause to arrange the appointment they’ve been putting off.